Novel boronic acid compounds derived from benzaldehydes, acetophenones, and Knoevenagel condensation, along with 3-aryl-1,4-naphthoquinones, designed as potential anti-inflammatory, anticancer, and antitubercular agents.
This research focuses on the design and synthesis of novel boronic acid compounds and 3-aryl-1,4-naphthoquinones as potential therapeutic agents. The boronic acids are derived from benzaldehydes, acetophenones, and Knoevenagel condensation reactions, providing diverse chemical scaffolds for drug discovery. The compounds are being developed with multiple therapeutic targets in mind, including anti-inflammatory, anticancer, and antitubercular applications.
Key research areas:
This research is at an early discovery stage, focused on the design and synthesis of novel chemical entities. Biological validation procedures and future validation plans are currently being developed to assess the therapeutic potential of these compounds.